Scilex Holding Co
Biotechnology company · Palo Alto, California, United States · Nasdaq: SCLX
Scilex Holding Co is a biotechnology company headquartered in Palo Alto, California, United States. Its earliest recorded incorporation is in 2020. Its shares trade on Nasdaq under the ticker SCLX. It has reported private securities offerings to the US SEC, most recently $2.7 million sold in a notice filed in 2025.
Scilex Holding at a glance
What does Scilex Holding do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $2.7 million sold (2025).
Frequently asked questions about Scilex Holding
Where is Scilex Holding headquartered?
Scilex Holding Co is headquartered in Palo Alto, California, United States.
What does Scilex Holding do?
Scilex Holding Co is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Scilex Holding a public company?
Yes. Scilex Holding Co trades on Nasdaq under the ticker SCLX.
When was Scilex Holding founded?
The earliest incorporation on record for Scilex Holding Co is in 2020, according to public company registers.
Similar companies
- Exai Bio Inc.Palo Alto, California, United States
- Kodiak Sciences Inc.Palo Alto, California, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.